DNMT3A mutations emerged as potential biomarkers for enhanced immunotherapy benefit in non-small cell lung cancer.

Nuvation Bio Inc. (NYSE:NUVB) is one of the 10 best healthcare penny stocks to buy according to analysts. JMP Securities ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

A new research paper was published in Volume 16 of Oncotarget on June 17, 2025, titled "Molecular landscape of HER2-mutated ...

A study led by Dana-Farber Cancer Institute researchers found that combining chemotherapy and immunotherapy before surgery ...

Pedro Valencia, VP, asset strategy, leadership, oncology, AbbVie, outlines how the company is accelerating development across ...

Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...

Elevated NLR may no longer predict poor survival outcomes in patients with small cell lung cancer (SCLC) receiving ...

Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

The company said the therapy is the first allogenic therapy developed with its Tmod technology to be tested in humans.